Change of Nominated Adviser
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your CREO notes
Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces that following the acquisition of Numis Securities Limited's parent company by Deutsche Bank AG on 23 October 2023 and its ongoing integration, its Nominated Adviser and Broker has changed from Numis Securities Limited to Deutsche Bank AG, London Branch with immediate effect.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.